Professional Affiliation

Vice President, Commercial Operations
Nuvelo

Expert Bio

Mr. Fleming is the Vice President, Commercial Operations to Nuvelo. Formerly from Genentech, where he held a senior position in its commercial organization and was responsible for marketing efforts associated with its hematology franchise, overseeing the U.S. Rituxan hematology/oncology commercial strategy and operations.Prior to joining Genentech, Mr. Fleming spent nearly 16 years with GlaxoSmithKline (GSK) and its precursor companies in both the United States and Canada. Most recently, he served as senior director of global commercial strategy for oncology, where he was responsible for leading the global commercial strategy and lifecycle management of oncology assets to enable successful worldwide commercialization. While with GSK, Mr. Fleming also served as vice president of the HIV, oncology and vaccines business unit in Canada and was a member of the Canadian management team. In addition, Mr. Fleming served on the management team of the Canadian operating company of Smithkline Beecham as head of its healthcare policy, strategic relations and market access division. He was also a member of the commercial operations integration taskforce and co-chair of the public affairs and market access integration taskforce during the merger of GlaxoWellcome and SmithKline Beecham in Canada.Mr. Fleming earned his masters degree in business administration and his bachelor of science at the University of Toronto, Canada.